Nigeria’s banking giant Guaranty Trust Holding Company (GTCO) has encountered a new regulatory holdup in its East African unit following a slamming of KSh 33.18 million ($257,000) fine on Guaranty Trust Bank Kenya. Kenya’s Competition Authority (CAK) decided on February 24, 2026, that the GTCO’s Kenyan outpost engaged in unfair and misleading conduct during the management and renewal of a corporate credit facility with a local client, ASL Limited. CAK also ordered GTB Kenya to refund improperly charged fees” of up to KSh 13.21 million ($102,000) to ASL, saying it represents improperly charged fees, retroactive default interest applied without notice, and fees on unapproved facilities.
ASL, an old corporate obligor, had lodged a complaint in 2024 against GT Bank. CAK investigated and found the Bank guilty of mischaracterizing altered credit terms as mere renewals and charging fees on delayed approvals, in violation of Kenya’s Competition Act sections on false advertising and unfair practices. But GT Bank in its appeal that it is innocent, claiming their actions are consistent with standard commercial negotiations. The fine depicts Kenya’s penchant for scrutinising foreign banks more intensely to protect consumers; it is fixed at 2 per cent of the unit’s 2023 revenue.
What it means for earnings and valuation
Hek thinks the impact on future earnings is negligible as the combined penalty and refund amount to c.$359,000, which barely scratches GTCO’s 2025 group-wide profits of $311 million. As the Kenya unit furnishes less than five per cent of GTCO’s revenue, there is no tangible tug on 2026 projections. But there are looming indirect costs in the guise of heightened compliance spending to revamp processes, which could peck at margins in its markets. Failure of the appeal might even induce copyist complaints, erode trust, and slow loan growth in a region where GTCO aims to achieve expansion through digital banking.
For valuations, only a mild chill may be felt. GTCO trades at a trailing twelve months (TTM) P/E of around 6.8x on the Nigerian Exchange. This reflects sturdy domestic dominance but vulnerability to pan-African risks. The minuscule fine rekindles memories of earlier penalties, and the Kenyan regulatory rebuke raises a “reputational discount” risk. Thus, GTCO share premium valuation relative to peers could shrink if investors think that the corporate banking strategy penalized in Nairobi is hostile, and that it could surface in other subsidiaries.
Hek argues that the regulatory action against GT Bank Kenya is a spur for governance and compliance focus rather than a material earnings shock. Yet investors should observe regulatory enforcement trends and how GTCO adjusts its practices to align with evolving expectations.
Capex discipline in Nigerian companies: Separating winners from bystanders
Corporate capital expenditure is back in the spotlight amid Nigerian equities recovery from the years of stagnancy. Nigerian companies had witnessed a protracted period of weak investment hushed by foreign exchange volatility, high interest rates and subdued demand Now, many of them have announced bold capex plans. But amid the sounds of capex bells, investors are wondering whether it will morph into sustainable earnings and superior returns or whether poor governance will douse the flames of potential gains.
Top Nigerian firms had spent billions on property, plant, and equipment (PPE) as of September 2025. MTN Nigeria led the pack with N539.6 billion spending, representing a 59 per cent rise over 2024, as it hoped to boost network expansions to meet booming data demand. Next, Dangote Cement bet on the Nigeria’s lingering infrastructure shortage to post N461.8 billion capex spending. This trend is dominated by telecoms, cement makers, oil producers, and banks, indicating a strategic buffer against economic headwinds.
Impact expectations versus reality
Spending on capital expenditure should enhance maintainable earnings and investor returns in the subsequent years, given increased capacity, expectations of enhanced efficiency and revenue streams that are critical to long-term profitability. Empirical studies have affirmed that capital expenditure significantly lifts return on investment in Nigerian production companies, with sustainable economic capital outlays improving financial performance across manufacturing sectors.
But has this expectation crystallised for Nigerian companies? There are pieces of evidence to positive but uneven outcomes. Nigerian equities were pushed by banking, telecom, and industrial gains to surge 31 per cent in dollar terms through early 2026 and place second globally. Again, the earnings growth of MTN and Dangote has correlated with the firms’ investments as market capitalization cracked the N100 trillion wall in January 2026, though Naira devaluation and high inflation reduced real returns in some instances as power shortages drove some firms to struggle with underutilized assets.
Moderating Capex spending for value creation
Good corporate governance births robust boards with independent oversight that ensures capex proposals are subjected to rigorous scrutiny, are aligned with strategic priorities and are justified by credible return forecasts. Nigeria generally has a weak institutional environment and thus depends on foreign institutional investors to import robust practices that will enhance oversight and curb wasteful spending. For investors therefore, governance tightening will steer the country’s capex boom to catalyse upside. As such, policymakers should enforce stricter codes to ensure that capex spending is turned into a promise rather than a mere prayer.
Nestlé Nigeria’s long road to sweet payout Rrcovery
After two years in the red with bruising losses of over N300 billion, Nestlé Nigeria has staged an emphatic turnaround with 2025 after-profit of N105 billion from revenues that jumped 26 per cent from the previous year to N1.21 trillion as robust demand for staples like Maggi and Milo merged with favourable pricing to support sales.
Furthermore, Naira stabilised and cut foreign exchange losses to buoy operating profits to N225.4 billion, 34 per cent rise from prior year. Meanwhile, negative equity of N92.3 billion turned to a positive N12.9 billion, with negative retained earnings halving to N112.8 billion. These will leave investors who endured Nestle’s 2024 lows enthused but disenchanted by the lingering long path to cash returns.
The recovery drivers
Operational spunk underpinned Nestle’s remarkable turnaround, with CEO Wassim Elhusseini crediting “renewed operational efficiency” and cost discipline for the positive outcome: $40 million in forex debt was repaid early and export sales spiked 56 per cent to N10.2 billion. This is not just window-dressing, but a shift from the currency devaluation woes of 2023/2024 that battered imported inputs. And there are signs that earnings growth will be sustained as Naira stability is reinforced by recent central bank reforms.
Analysts project that annual earnings will climb 16.4 per cent in the next three years, that revenue could rise by 14.1 per cent, and that return on equity should hit 61 per cent. Core operations reflect resilience as free cash flow is sufficiently robust to support reinvestment and analysts say earnings per share will rise from the crud to stabilise around N132 if there are no considerable FX shocks.
Dividends, valuation and near-term import
Investors should adorn the patience garb concerning dividend, which was suspended since 2022 in the face of losses. Because as profits cover negative retained earnings, payouts beckon on the corner. Management says it is “optimistic” dividend payment will “soon” resume. This may be in 2026 if the trends stay. Analysts’ models forecast dividend yield of 6.5 per cent in 2025, sufficient to lure income seekers.
What is more, valuation seems reasonable. At a share price of N3,100, up 218 per cent annually, the trailing P/E is 23.41. Forward P/E is estimated at around 10, suggesting undervaluation relative to growth. Nestle’s near-term is Bullish assuming a steadied Nigerian economy. The stock’s 218 per cent 52-week gain shows momentum, offering a sweet blend of growth and income potential for patient investors.
